- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03468738
Investigation of the Transfusion Practices in Surgical Patients in Turkey (CeKATU)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patient Blood Management (PBM) is an evidence based multidisciplinary approach for the care of patients who may need blood transfusion. The aim of PBM is achieving better patient outcomes by focusing on the patients' own blood as a source.
To date PBM is considered "good transfusion practice" and is being implemented in a growing number of countries. The Turkish Society of Anesthesiologists PBM Task Force is working on this subject since 4 years and decided to conduct a study. Before starting a PBM program, the transfusion practices of clinicians working at diverse surgical fields; differences between current transfusion practices and PBM strategies; the areas for improvement and the obstacles that could prevent change could be identified with this study. Data collection will also serve to identify the current situation as a reference and to control the achievement of the PBM's aim: improving clinical outcomes. These data will be refered as The Turkish National Perioperative Transfusion Study (TULIP TS) data.
The aim of this study is to describe the transfusion practices in patients undergoing major surgery in Turkey.
The study evaluates i. The perioperative transfusion rates of RBCs, FFP and platelets. ii. With which reasons the anesthesiologists decide to transfuse a patient (co morbidities of the patients, physiologic transfusion triggers, hemoglobin trigger, uncontrolled bleeding, on request from surgeon etc.).
iii. The relation of transfusion and the patients co-morbidity index, the P POSSUM score and SORT score; anesthesia methods; monitorisation methods (hemodynamic, coagulation); amount of bleeding; type of surgery; type of hospital.
iv. The relation of transfusion and patient outcomes (unanticipated ICU admission, prolonged ICU stay, acute renal failure, thromboembolic events, ischemic events, pulmonary complications, cardiac advers events, infections, acute respiratory distress, infection, all-cause mortality).
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey
- Gazi University Medical Faculty
-
Ankara, Turkey
- Hacettepe University Medical Faculty
-
Ankara, Turkey
- Ankara University Ibni Sina Hospital
-
Ankara, Turkey
- Baskent University Ankara Hospital
-
Ankara, Turkey
- Acibadem University Mehmet Ali Aydinlar Atakent Hospital
-
Ankara, Turkey
- Ankara University Cebeci Medical Center
-
Ankara, Turkey
- Private Cankaya Hospital
-
Ankara, Turkey
- Ufuk University Medical Faculty Dr. Ridvan Ege Training and Research Hospital
-
Ankara, Turkey
- University of Health sciences Ankara Child Health and Diseases Hematology Oncology Training and research Hospital
-
Ankara, Turkey
- University of Health Sciences Ankara Numune Training and Research Hospital
-
Ankara, Turkey
- University of Health Sciences Ankara Training and Research Hospital
-
Ankara, Turkey
- University of Health Sciences Diskapi Yildirim Beyazit Trainig Research Hospital
-
Ankara, Turkey
- University of Health Sciences Dr Abdurrahman Yurtaslanı Ankara Oncology Training and Research Hospital
-
Ankara, Turkey
- University of Health Sciences Kecioren Training and Research Hospital
-
Ankara, Turkey
- University of Health Sciences Turkiye Yuksek Ihtisas Training and Research Hospital
-
Ankara, Turkey
- University of Health Sciences Yenimahalle Training and Research Hospital
-
Ankara, Turkey
- University of Health Sciences Zubeyde Hanim Gynecology and Maternity Training and Research Hospital
-
Ankara, Turkey
- University of Technology and Economics Medical Faculty
-
Antalya, Turkey
- Akdeniz University Medical Faculty
-
Antalya, Turkey
- University of Health Sciences Antalya Training and Research Hospital
-
Balıkesir, Turkey
- Balikesir University Training and Research Hospital
-
Bursa, Turkey
- Uludag University Medical Faculty
-
Bursa, Turkey
- University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital
-
Edirne, Turkey
- Trakya University Medical Faculty
-
Elazığ, Turkey
- Fırat University Medical Faculty
-
Erzincan, Turkey
- Erzincan University Mengucek Gazi Training and Research Hospital
-
Eskişehir, Turkey
- Eskisehir Osmangazi University Medical Faculty
-
Isparta, Turkey
- Suleyman Demirel University Medical Faculty
-
Istanbul, Turkey
- Istanbul University Medical Faculty
-
Istanbul, Turkey
- Marmara University Pendik Training and Research Hospital
-
Istanbul, Turkey
- Acibadem University Altunizade Hospital
-
Istanbul, Turkey
- University of Health Sciences Fatih Sultan Mehmet Training and Research Hospital
-
Istanbul, Turkey
- University of Health Sciences Haydarpasa Numne Training and Research Hospital
-
Istanbul, Turkey
- University of Health Sciences Istanbul Training and Research Hospital
-
Istanbul, Turkey
- University of Health Sciences Kanuni Sultan Suleyman Training and Research Hospital
-
Istanbul, Turkey
- University of Health Sciences Okmeydanı Training and Research Hospital
-
Istanbul, Turkey
- University of Health Sciences Umraniye Training and Research Hospital
-
Kahramanmaraş, Turkey
- Sutcu Imam University Medical Faculty
-
Kayseri, Turkey
- Erciyes University Medical Faculty
-
Kayseri, Turkey
- University of Health Sciences Kayseri Training and Research Hospital
-
Kocaeli, Turkey
- Anadolu Health Center Hospital
-
Kocaeli, Turkey
- University of Health Sciences Derince Training and Research Hospital
-
Konya, Turkey
- Selcuk University Medical Faculty
-
Konya, Turkey
- Necmettin Erbakan University Meram Medical Faculty Center for Health and Research
-
Konya, Turkey
- University of Health Sciences Konya Training and Research Hospital
-
Malatya, Turkey
- Inonu University Liver Transplantation Institute
-
Manisa, Turkey
- Manisa Celal Bayar University Medical Faculty Hafsa Sultan Hospital
-
Mersin, Turkey
- Mersin University Medical Faculty
-
Ordu, Turkey
- Ordu University Medical Faculty
-
Osmaniye, Turkey
- Osmaniye State Hospital
-
Samsun, Turkey
- Ondokuz Mayıs University Medical Faculty
-
Tekirdağ, Turkey
- Namık Kemal University Medical Faculty
-
Trabzon, Turkey
- Karadeniz Technical University Medical Faculty Farabi Hospital
-
Tunceli, Turkey
- Tunceli State Hospital
-
Van, Turkey
- Van Yuzuncuyıl University Medical Faculty Dursun Odabası Center
-
Zonguldak, Turkey
- Bulent Ecevit University Medical Faculty Center for Health and Research
-
Çorum, Turkey
- Hitit University Corum Erol Olcok Training and Research Hospital
-
İstanbul, Turkey
- Istanbul Medeniyet University Goztepe Training and Research Hospital
-
İzmir, Turkey
- Dokuz Eylul University Medical Faculty
-
İzmir, Turkey
- University of Health Sciences Bozyaka Training Research Hospital
-
İzmir, Turkey
- University of Health Sciences Izmir Tepecik Training and Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients undergoing major elective surgery
Exclusion Criteria:
Trauma patients, emergency surgery
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preoperative amount of blood products transfused
Time Frame: Before surgery at day 0
|
Preoperative amount of blood products: RBCs,FFP and platelets transfused
|
Before surgery at day 0
|
Intraoperative amount of blood products transfused
Time Frame: During surgery at day 0
|
Intraoperative amount of blood products: RBC's,FFP and platelets transfused
|
During surgery at day 0
|
Postoperative amount of blood products transfused
Time Frame: 24 hours after surgery
|
Postoperative amount of blood products: RBCs,FFP and platelets transfused
|
24 hours after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Preoperative transfusion indications
Time Frame: Before surgery at day 0
|
The reasons to decide to transfuse (factors determining transfusion) blood products
|
Before surgery at day 0
|
Intraoperative transfusion indications
Time Frame: During surgery at day 1
|
The reasons to decide to transfuse (factors determining transfusion) blood products
|
During surgery at day 1
|
Postoperative transfusion indications
Time Frame: 24 hours after surgery
|
The reasons to decide to transfuse (factors determining transfusion) blood products
|
24 hours after surgery
|
Unanticipated ICU admission
Time Frame: After surgery at day 1
|
Whether the patient had an unanticipated ICU admission
|
After surgery at day 1
|
Prolonged length of stay in ICU
Time Frame: After surgery at day 2
|
Whether the patient had a prolonged length of stay in ICU
|
After surgery at day 2
|
Acute renal failure
Time Frame: After surgery at day 2
|
Whether the patient had acute renal failure
|
After surgery at day 2
|
Thromboembolic event
Time Frame: After surgery at day 2
|
Whether the patient had a thromboembolic event concerning lungs (pulmonary embolism), brain (stroke), gastrointestinal tract, kidneys, or extremities etc.
|
After surgery at day 2
|
Ischemic event
Time Frame: After surgery at day 2
|
Whether the patient had an ischemic event concerning heart, nervous system,limb, gastrointestinal tract etc.
|
After surgery at day 2
|
Infection
Time Frame: After surgery at day 2
|
Whether the patient had infection: wound, pneumonia, urinary, sepsis etc.
|
After surgery at day 2
|
Acute respiratory distress
Time Frame: After surgery at day 2
|
Whether the patient had acute respiratory distress
|
After surgery at day 2
|
Mortality
Time Frame: after surgery at day 30
|
Whether the patient died: all cause mortality
|
after surgery at day 30
|
Preoperative anemia
Time Frame: Before surgery at day 0
|
Whether the patient had anemia (Hemoglobin male < 13 female < 12 g/dL)
|
Before surgery at day 0
|
Preoperative coagulopathy
Time Frame: Before surgery at day 0
|
Whether the patient had coagulopathy due to disease or drugs
|
Before surgery at day 0
|
Pretransfusion hemoglobin values
Time Frame: Before surgery at day 0
|
The hemoglobin concentration before transfusion
|
Before surgery at day 0
|
Pretransfusion hemoglobin values
Time Frame: During surgery at day 1
|
The hemoglobin concentration before transfusion
|
During surgery at day 1
|
Pretransfusion hemoglobin values
Time Frame: After surgery at day 2
|
The hemoglobin concentration before transfusion
|
After surgery at day 2
|
Advers cardiac events
Time Frame: After surgery at day 30
|
Whether the patient had an advers cardiac event: myocardial infaction; non fatal cardiac arest; arrhytmia; cardiogenic pulmonary edema etc
|
After surgery at day 30
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Dilek Unal, Assoc Prof, Netherlands: Ministry of Health, Welfare and Sports
Publications and helpful links
General Publications
- Hsieh FY, Bloch DA, Larsen MD. A simple method of sample size calculation for linear and logistic regression. Stat Med. 1998 Jul 30;17(14):1623-34. doi: 10.1002/(sici)1097-0258(19980730)17:143.0.co;2-s.
- Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L, Angelini GD. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007 Nov 27;116(22):2544-52. doi: 10.1161/CIRCULATIONAHA.107.698977. Epub 2007 Nov 12.
- Meier J, Filipescu D, Kozek-Langenecker S, Llau Pitarch J, Mallett S, Martus P, Matot I; ETPOS collaborators. Intraoperative transfusion practices in Europe. Br J Anaesth. 2016 Feb;116(2):255-61. doi: 10.1093/bja/aev456.
- Kotze A, Carter LA, Scally AJ. Effect of a patient blood management programme on preoperative anaemia, transfusion rate, and outcome after primary hip or knee arthroplasty: a quality improvement cycle. Br J Anaesth. 2012 Jun;108(6):943-52. doi: 10.1093/bja/aes135.
- Kalil AC, Mattei J, Florescu DF, Sun J, Kalil RS. Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature. Am J Transplant. 2010 Jul;10(7):1686-94. doi: 10.1111/j.1600-6143.2010.03141.x.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Dilek Yazıcıoglu Unal
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anemia
-
SanofiActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)United States, Austria, China, Denmark, Germany, Hungary, Italy, Spain, United Kingdom
-
SanofiTerminatedWarm Autoimmune Hemolytic Anemia (wAIHA)United Kingdom, Belgium, Netherlands, France, United States, Germany, Hungary, Italy
-
Hospital Universitario Dr. Jose E. GonzalezCompletedPernicious Anemia | Megaloblastic Anemia NosMexico
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSevere Aplastic Anemia | Idiopathic Aplastic Anemia | Moderate Aplastic Anemia Requiring Transfusions
-
Abdelwahed, Mai Mahmoud Mohamed, M.D.UnknownAnemia During PregnancyEgypt
-
University of California, DavisInstituto Mexicano del Seguro Social; Thrasher Research Fund; Mexican National... and other collaboratorsCompleted
-
Incyte CorporationActive, not recruitingWarm Autoimmune Hemolytic Anemia (wAIHA)Spain, United States, Austria, Belgium, Canada, France, Germany, Israel, Italy, Japan, Netherlands, Poland, United Kingdom
-
Peking Union Medical College HospitalRecruiting
-
Alexion PharmaceuticalsWithdrawnWarm Autoimmune Hemolytic AnemiaUnited States
Clinical Trials on Blood transfusion
-
Hamad Medical CorporationSidra Medical and Research Center; World Anti-Doping Agency; Anti-Doping Lab... and other collaboratorsUnknownBlood Disease | Blood Transfusion, Autologous | Blood Doping | Blood Transfusion, HomologousQatar
-
Hospital PitangueirasUnknown
-
Emory UniversityWithdrawnHematopoietic and Lymphoid Cell Neoplasm | Leukemia | Anemia | Myelodysplastic Syndrome | Aplastic Anemia | Bone Marrow FailureUnited States
-
Haukeland University HospitalDentsply Sirona Implants and ConsumablesCompleted
-
Mahidol UniversityWolf Schleinzer Stiftung zur Wissenschafts- und Bildungsförderung, GermanyCompletedSurgery | Immune Defect | Incompatible Blood TransfusionThailand
-
Oregon Health and Science UniversityNot yet recruitingTraumatic Brain Injury
-
Assistance Publique - Hôpitaux de ParisCompletedMyocardial Infarction | Anemia | Blood TransfusionSpain, France
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia | Primary Myelofibrosis | Thrombocytopenia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Venous Thromboembolism | Myelodysplastic Syndrome | B-Cell Non-Hodgkin Lymphoma | Hematopoietic Cell Transplantation Recipient | Chronic Myelogenous Leukemia, BCR-ABL1 Positive and other conditionsUnited States
-
Direction Centrale du Service de Santé des ArméesFloralis; TIMC-IMAGRecruitingTrauma | Coagulopathy | Acute HemorrhageFrance
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; Etablissement... and other collaboratorsRecruitingThe Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy VolunteersFrance